Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-000329

Director acquired 18,208 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Yorke Justin W Director 2022-12-31 Grant or award +18,208 33,093 D
Derivatives
Yorke Justin W Director 2023-01-01 Grant or award · Restricted Stock +30,000 30,000 D
Loading xslF345X03/doc1.xml…